4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate

C66H81Br2Cl2N17O7 — CID 157487119

IUPAC4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CCC(NC(=O)N2CCN(C3c4ccc(Cl)cc4CCc4cc(Br)cnc43)CC2C(=O)NCCn2ccnc2)CC1.NC(=O)N1CCC(NC(=O)N2CCN(C3c4ccc(Cl)cc4CCc4cc(Br)cnc43)CC2C(=O)NCCn2ccnc2)CC1
InChIInChI=1S/C35H44BrClN8O4.C31H37BrClN9O3/c1-35(2,3)49-34(48)43-12-8-27(9-13-43)41-33(47)45-17-16-44(21-29(45)32(46)39-11-15-42-14-10-38-22-42)31-28-7-6-26(37)19-23(28)4-5-24-18-25(36)20-40-30(24)31;32-22-15-21-2-1-20-16-23(33)3-4-25(20)28(27(21)37-17-22)41-13-14-42(31(45)38-24-5-9-40(10-6-24)30(34)44)26(18-41)29(43)36-8-12-39-11-7-35-19-39/h6-7,10,14,18-20,22,27,29,31H,4-5,8-9,11-13,15-17,21H2,1-3H3,(H,39,46)(H,41,47);3-4,7,11,15-17,19,24,26,28H,1-2,5-6,8-10,12-14,18H2,(H2,34,44)(H,36,43)(H,38,45)
InChIKeyBWVRAZBDPCMTBN-UHFFFAOYSA-N
MW1455.20 g/mol
LogP7.73
Rot. Bonds12

About 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate

4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate (PubChem CID 157487119) has the molecular formula C66H81Br2Cl2N17O7 and a molecular weight of 1455.20 g/mol. Its IUPAC name is 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate.

Molecular Properties

Compound Name4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate
PubChem CID157487119
Molecular FormulaC66H81Br2Cl2N17O7
Molecular Weight1455.20 g/mol
Exact Mass1451.42
IUPAC Name4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CCC(NC(=O)N2CCN(C3c4ccc(Cl)cc4CCc4cc(Br)cnc43)CC2C(=O)NCCn2ccnc2)CC1.NC(=O)N1CCC(NC(=O)N2CCN(C3c4ccc(Cl)cc4CCc4cc(Br)cnc43)CC2C(=O)NCCn2ccnc2)CC1
InChIInChI=1S/C35H44BrClN8O4.C31H37BrClN9O3/c1-35(2,3)49-34(48)43-12-8-27(9-13-43)41-33(47)45-17-16-44(21-29(45)32(46)39-11-15-42-14-10-38-22-42)31-28-7-6-26(37)19-23(28)4-5-24-18-25(36)20-40-30(24)31;32-22-15-21-2-1-20-16-23(33)3-4-25(20)28(27(21)37-17-22)41-13-14-42(31(45)38-24-5-9-40(10-6-24)30(34)44)26(18-41)29(43)36-8-12-39-11-7-35-19-39/h6-7,10,14,18-20,22,27,29,31H,4-5,8-9,11-13,15-17,21H2,1-3H3,(H,39,46)(H,41,47);3-4,7,11,15-17,19,24,26,28H,1-2,5-6,8-10,12-14,18H2,(H2,34,44)(H,36,43)(H,38,45)
InChIKeyBWVRAZBDPCMTBN-UHFFFAOYSA-N
XLogP7.73
TPSA266.65 Ų
H-Bond Donors5
H-Bond Acceptors15
Rotatable Bonds12
Heavy Atoms94
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001455.20
LogP ≤ 57.73
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1015

Analyze 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate?
The IUPAC name of 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate (CID 157487119) is 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate.
What is the SMILES notation for 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate?
The canonical SMILES for 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate is CC(C)(C)OC(=O)N1CCC(NC(=O)N2CCN(C3c4ccc(Cl)cc4CCc4cc(Br)cnc43)CC2C(=O)NCCn2ccnc2)CC1.NC(=O)N1CCC(NC(=O)N2CCN(C3c4ccc(Cl)cc4CCc4cc(Br)cnc43)CC2C(=O)NCCn2ccnc2)CC1.
What is the InChIKey of 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate?
The InChIKey is BWVRAZBDPCMTBN-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H44BrClN8O4.C31H37BrClN9O3/c1-35(2,3)49-34(48)43-12-8-27(9-13-43)41-33(47)45-17-16-44(21-29(45)32(46)39-11-15-42-14-10-38-22-42)31-28-7-6-26(37)19-23(28)4-5-24-18-25(36)20-40-30(24)31;32-22-15-21-2-1-20-16-23(33)3-4-25(20)28(27(21)37-17-22)41-13-14-42(31(45)38-24-5-9-40(10-6-24)30(34)44)26(18-41)29(43)36-8-12-39-11-7-35-19-39/h6-7,10,14,18-20,22,27,29,31H,4-5,8-9,11-13,15-17,21H2,1-3H3,(H,39,46)(H,41,47);3-4,7,11,15-17,19,24,26,28H,1-2,5-6,8-10,12-14,18H2,(H2,34,44)(H,36,43)(H,38,45).
What are the key properties of 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate?
4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate has a molecular weight of 1455.20 g/mol, XLogP of 7.73, 12 rotatable bonds, 5 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-1-N-(1-carbamoylpiperidin-4-yl)-2-N-(2-imidazol-1-ylethyl)piperazine-1,2-dicarboxamide;tert-butyl 4-[[4-(6-bromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-(2-imidazol-1-ylethylcarbamoyl)piperazine-1-carbonyl]amino]piperidine-1-carboxylate is sourced from PubChem (CID 157487119), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).